Clinical Trial Update: Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating immunoadsorption and intravenous immunoglobulin substitution for heart failure after myocardial infarction has been withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Failure

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University Medicine Greifswald | Conditions: Heart Failure, Coronary Heart Disease | Phase 1, Phase 2 | Status: WITHDRAWN